Background illustration for clinical trials search

Paid Clinical Trials Bellevue

Discover 603 paid clinical trials in Bellevue, Nebraska. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 603

An Efficacy and Safety Study of Clemizole HCl in Patients With Lennox-Gastaut Syndrome

for

Lennox Gastaut Syndrome

Location: Omaha NE, Roseville MN, Chicago IL, Louisville KY,

Sponsor: Epygenix

Sex: All

Age: 2 - 55

Code: NCT05066217

Phase3, Recruiting

National Collaborative to Improve Care of Children With Complex Congenital Heart Disease

for

Hypoplastic Left Heart Syndrome (HLHS)

Location: Omaha NE, Kansas City MO, Iowa City IA, Minneapolis MN,

Sponsor: Children's Hospital Medical Center, Cincinnati

Sex: All

Age: 0 - 1

Code: NCT02852031

Recruiting

A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease

for

Sickle Cell Disease

Location: Omaha NE, Minneapolis MN, St Louis MO, Oklahoma City OK,

Sponsor: Novo Nordisk A/S

Sex: All

Age: 12+

Code: NCT06612268

Phase3, Recruiting

I-DECIDE After Bronchiolitis Hospitalization

for

Bronchiolitis Acute

Location: Omaha NE, Lincoln NE, Kansas City MO, Springfield MO,

Sponsor: Seattle Children's Hospital

Sex: All

Age: 0 - 2

Code: NCT07243652

Recruiting

A Study to Learn About the Study Medicine Called Zavegepant (PF-07930207) in Children With a History of Migraine

for

Acute Treatment of Migraine

Location: Omaha NE, Tulsa OK, Dallas TX, Hinesville GA,

Sponsor: Pfizer

Sex: All

Age: 6 - 11

Code: NCT06995729

Phase1, Recruiting

Validating a Blood Test for the Detection of Traumatic Brain Injury in Children

for

Pediatric Traumatic Brain Injury

Location: Omaha NE

Sponsor: University of Nebraska

Sex: All

Age: 0 - 17

Code: NCT06940232

Recruiting

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

for

B Acute Lymphoblastic Leukemia

Location: Omaha NE, Des Moines IA, Kansas City MO, Sioux Falls SD,

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 1 - 46

Code: NCT06124157

Phase2, Recruiting

Improving Safety and Quality of Tracheal Intubation Practice in Pediatric ICUs

for

Failed or Difficult Intubation, Sequela, Intubation; Difficult,

Location: Omaha NE, Madison WI, Shorewood Hills WI, Milwaukee WI,

Sponsor: Children's Hospital of Philadelphia

Sex: All

Age: 0+

Code: NCT02493478

Recruiting

The Pediatric Anesthesia Quality Improvement Project

for

Surgery, Anesthesia, Children

Location: Omaha NE, Iowa City IA, ST Louis MO, Chicago IL,

Sponsor: The Society for Pediatric Anesthesia

Sex: All

Age: 0 - 21

Code: NCT00674388

Recruiting

A Study of EPX-100 (Clemizole Hydrochloride) in Participants With Dravet Syndrome

for

Dravet Syndrome

Location: Omaha NE, Little Rock AR, Louisville KY, Cincinnati OH,

Sponsor: Epygenix

Sex: All

Age: 2+

Code: NCT04462770

Phase3, Recruiting

Randomized Study in Children and Adolescents With Migraine: Acute Treatment

for

Pediatric Migraine

Location: Omaha NE, Sioux City IA, West Des Moines IA,

Sponsor: Pfizer

Sex: All

Age: 6 - 17

Code: NCT04649242

Phase3, Recruiting

Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine

for

Acute Treatment of Migraine

Location: Omaha NE, West Des Moines IA, Kansas City KS,

Sponsor: Pfizer

Sex: All

Age: 6 - 17

Code: NCT04743141

Phase3, Recruiting

Non-Invasive Diagnosis of Pediatric Pulmonary Invasive Mold Infections

for

Pulmonary Invasive Fungal Infections,

Location: Omaha NE, Kansas City MO, Saint Paul MN, Saint Louis MO,

Sponsor: Arkansas Children's Hospital Research Institute

Sex: All

Age: 0 - 21

Code: NCT03827694

Recruiting

Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

for

Acute Leukemia of Ambiguous Lineage,

Location: Omaha NE, Des Moines IA, Kansas City MO, Sioux Falls SD,

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 0 - 1

Code: NCT06317662

Phase2, Recruiting

A Clinical Trial Comparing 2x/Day for 30-minutes Use of the Emanate Perio PODS Post-SRP to a Control Group Post-SRP.

for

Periodontitis (Stage 3)

Location: La Vista NE, Spring TX, Houston TX, Richmond VA,

Sponsor: McGuire Institute

Sex: All

Age: 30 - 70+

Code: NCT06914596

Recruiting

An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.

for

Oligometastatic Prostate Cancer (OMPC)

Location: Omaha NE, Des Moines IA, Kansas City KS, Rochester MN,

Sponsor: Novartis Pharmaceuticals

Sex: Male

Age: 18 - 70+

Code: NCT05939414

Phase3, Recruiting

A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer

for

Non-Muscle Invasive Bladder Cancer

Location: Omaha NE, Wichita KS, St Louis MO, Chicago IL,

Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT06319820

Phase3, Recruiting

Detrusor Nerve Radiofrequency Ablation for Overactive Bladder in Women

for

Overactive Bladder, Overactive Bladder (OAB),

Location: Omaha NE, Wichita KS, Winston-Salem NC, Boise ID,

Sponsor: InMode MD Ltd.

Sex: Female

Age: 22 - 70+

Code: NCT07209397

Recruiting

IC-8 Apthera IOL New Enrollment Post Approval Study

for

Cataract, Presbyopia, Posterior Capsule Opacification

Location: Omaha NE, Wichita KS, Rock Island IL, Indianapolis IN,

Sponsor: Bausch & Lomb Incorporated

Sex: All

Age: 22+

Code: NCT06060041

Recruiting

Investigator Initiated Study to Assess the Efficacy of OC-01 (Varenicline) Nasal Spray on Signs and Symptoms of Dry Eye Disease Following Photorefractive Keratectomy (PRK)

for

Dry Eye

Location: Omaha NE

Sponsor: Brandon Baartman

Sex: All

Age: 18+

Code: NCT05045508

Phase3, Recruiting

Paid Clinical Trials Bellevue

Filter results

An Efficacy and Safety Study of Clemizole HCl in Patients With Lennox-Gastaut Syndrome

National Collaborative to Improve Care of Children With Complex Congenital Heart Disease

A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease

I-DECIDE After Bronchiolitis Hospitalization

A Study to Learn About the Study Medicine Called Zavegepant (PF-07930207) in Children With a History of Migraine

Interested in new trials?

Validating a Blood Test for the Detection of Traumatic Brain Injury in Children

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

Improving Safety and Quality of Tracheal Intubation Practice in Pediatric ICUs

The Pediatric Anesthesia Quality Improvement Project

A Study of EPX-100 (Clemizole Hydrochloride) in Participants With Dravet Syndrome

Randomized Study in Children and Adolescents With Migraine: Acute Treatment

Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine

Non-Invasive Diagnosis of Pediatric Pulmonary Invasive Mold Infections

Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

A Clinical Trial Comparing 2x/Day for 30-minutes Use of the Emanate Perio PODS Post-SRP to a Control Group Post-SRP.

An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.

A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer

Detrusor Nerve Radiofrequency Ablation for Overactive Bladder in Women

IC-8 Apthera IOL New Enrollment Post Approval Study

Investigator Initiated Study to Assess the Efficacy of OC-01 (Varenicline) Nasal Spray on Signs and Symptoms of Dry Eye Disease Following Photorefractive Keratectomy (PRK)